Candriam SCA’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.15M | Sell |
1,172,387
-32,820
| -3% | -$228K | 0.05% | 279 |
|
|
2025
Q1 | $10.2M | Buy |
1,205,207
+117,331
| +11% | +$996K | 0.06% | 235 |
|
|
2024
Q4 | $15.2M | Buy |
1,087,876
+37,278
| +4% | +$522K | 0.09% | 207 |
|
|
2024
Q3 | $23.8M | Buy |
1,050,598
+291,418
| +38% | +$6.59M | 0.14% | 154 |
|
|
2024
Q2 | $15.4M | Sell |
759,180
-130,078
| -15% | -$2.63M | 0.09% | 207 |
|
|
2024
Q1 | $22.1M | Buy |
889,258
+20,000
| +2% | +$498K | 0.14% | 151 |
|
|
2023
Q4 | $15.7M | Sell |
869,258
-384,003
| -31% | -$6.94M | 0.11% | 190 |
|
|
2023
Q3 | $25.2M | Sell |
1,253,261
-20,000
| -2% | -$402K | 0.18% | 114 |
|
|
2023
Q2 | $32.5M | Sell |
1,273,261
-29,950
| -2% | -$764K | 0.23% | 110 |
|
|
2023
Q1 | $25.5M | Buy |
1,303,211
+128,000
| +11% | +$2.51M | 0.18% | 138 |
|
|
2022
Q4 | $34.8M | Sell |
1,175,211
-57,043
| -5% | -$1.69M | 0.23% | 100 |
|
|
2022
Q3 | $28.7M | Buy |
1,232,254
+397,578
| +48% | +$9.25M | 0.2% | 113 |
|
|
2022
Q2 | $14M | Buy |
+834,676
| New | +$14M | 0.12% | 180 |
|